结核性脑膜炎治疗前后ESAT-6和IL-10的水平变化及意义

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (29 KB)
Export: BibTeX | EndNote (RIS)

Abstract ObjectiveTo explore the changes of levels of ESAT-6 and IL-10 before and after the treatment of tubercular meningitis and its clinical significance.Methods52 patients with tubercular meningitis who were admitted to our hospital from March 2014 to March 2016 were selected as the observation group,and 33 patients without tubercular meningitis who were admitted to our hospital during the same period of time were selected as the control group.The changes of levels of ESAT-6 and IL-10 before and after the treatment were compared and analyzed between the two groups.ResultsThe levels of ESAT-6 and IL-10 before the treatment in the observation group were significantly higher than those in the control group(P＜0.05).After treatment,the levels of ESAT-6 and IL-10 in the observation group were significantly lower than those before treatment,and the differences with in the group were statistically significant(P＜0.05).After treatment,the levels of ESAT-6 and IL-10 in the observation group were significantly higher than those in the control group,and the differences were statistically significant(P＜0.05).The differences of the levels of ESAT-6 and IL-10 in the control group before and after the treatment were not statistically significant(P＞0.05).ConclusionThe detection of ESAT-6 and IL-10 levels can evaluate the severity of disease for the patients with tubercular meningitis,which plays a guiding significance in formulating effective intervention measures and evaluating clinical efficacy.

Key words： Tubercular meningitis Treatment Decrease Degree

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Xiao-dan
	LV Yong-nian
	LI Qiu-juan
	WANG Xiao-hua

Cite this article:

GUO Xiao-dan,LV Yong-nian,LI Qiu-juan, et al. Changes of levels of ESAT-6 and IL-10 before and after the treatment of tubercular meningitis and its significance[J]. 中国当代医药, 2017, 24(35): 159-161.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2017/V24/I35/159

[15]	刘亚娟，何俊瑛，卜晖，等.改良抗酸染色阳性的170例结核性脑膜炎脑脊液分析[J].中国神经精神疾病杂志，2017，43（4）:215-219.
[1]	王晓平，李晓佳，罗向东，等.中枢神经系统感染患者的血清学分析及治疗[J].中华医院感染学杂志，2014，24（6）:1429-1431.
[2]	文安，张昆南.结核性脑膜炎结核分枝杆菌检测方法的研究进展[J].中国神经免疫学和神经病学杂志，2014，21（2）:141-144.
[3]	尹忠平，邓雷梅，罗昌菊，等.结核性脑膜炎患者地塞米松冲击治疗的临床研究[J].中华医院感染学杂志，2014，24（15）:3736-3738.
[4]	马江涛，吴文苑，张立军，等.ESAT-6、IL-8 和 INF-γ 在结核性脑膜炎早期诊断中的应用[J].中国卫生检验杂志，2014，24（14）:2027-2028.
[5]	张昆南，文安，杨赟，等.ELISA法检测浓缩脑脊液ESAT-6对结核性脑膜炎的诊断价值[J].中国神经免疫学和神经病学杂志，2014，21（5）:360-363.
[6]	张春晓，张崇，曹建玺，等.莫西沙星与抗结核药物联用综合治疗难治性结核性脑膜炎的疗效[J].中国老年学杂志，2015，35（8）:2085-2086.
[7]	汤海燕，谈鹰，张栗.脑脊液与血浆生化指标比值对结核性脑膜炎与化脓性脑膜炎的鉴别意义[J].中国全科医学，2015，18（14）:1705-1707.
[8]	职瑾，史明，冯国栋，等.脑脊液细胞中结核早期分泌性靶抗原6的检测及其早期诊断价值[J].细胞与分子免疫学杂志，2015，31（3）:387-390.
[9]	陈效友.成人结核性脑膜炎诊疗进展[J].中国实用内科杂志，2015，35（8）:661-667.
[10]	杨龙，张玉林，金福强.IL-6、IL-10、PLA2 在颅内感染中的水平变化及与预后的关系[J].重庆医学，2015，44（33）:4655-4657.
[11]	赵琰枫，冯晓燕，修冰水，等.结核分枝杆菌 ESAT-6+CFP-10融合抗原克隆表达及其生物学活性[J].军事医学，2016，40（3）:226-229.
[12]	刘卫国，刘传宝，王永亮，等.脑脊液单核细胞内结核分枝杆菌早期分泌性抗原检测对结核性脑膜炎早期诊断评价[J].中华医院感染学杂志，2016，26（14）:3135-3137.
[13]	张晓东，李晶超.糖皮质激素联合四联抗结核药物治疗老年结核性脑膜炎的疗效及对脑脊液细胞学的影响[J].中国老年学杂志，2017，37（4）:949-951.
[14]	黄四春，张忠胜.结核性脑膜炎诊治现状及进展[J].中国全科医学，2016，19（S1）:217-220.